A phase II trial of first-line sorafenib
โ
Joaquim Bellmunt; Pablo Maroto-Rey; Josรฉ M. Trigo; Joan Carles; Vicente Guillem;
๐
Article
๐
2010
๐
Springer Milan
๐
Spanish
โ 291 KB